Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 4/20 | 0.67 |
| ▸ | POLA1 | P09884 | 1/20 | 0.66 |
| ▸ | VDR | P11473 | 3/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.56 |
| ▸ | ST6GAL1 | P15907 | 1/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.54 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12798590 | 0.96 | CDC25A (0.62) | CDC25APOLA1VDRUSP2CYP2D6 | |
| SCHEMBL17124793 | 0.92 | CDC25A (0.66) | CDC25APOLA1VDRUSP2CYP2D6 | |
| SCHEMBL141358 | 0.92 | CDC25A (0.66) | CDC25APOLA1VDRUSP2CYP2D6 | |
| SCHEMBL20488562 | 0.92 | CDC25A (0.66) | CDC25APOLA1VDRUSP2CYP2D6 | |
| SCHEMBL17123439 | 0.92 | CDC25A (0.66) | CDC25APOLA1VDRUSP2CYP2D6 | |
| SCHEMBL25211248 | 0.92 | CDC25A (0.66) | CDC25APOLA1VDRUSP2CYP2D6 | |
| SCHEMBL27918611 | 0.92 | CDC25A (0.66) | CDC25APOLA1VDRUSP2CYP2D6 | |
| SCHEMBL21510590 | 0.92 | CDC25A (0.66) | CDC25APOLA1VDRUSP2CYP2D6 | |
| SCHEMBL13412384 | 0.92 | CDC25A (0.67) | CDC25APOLA1VDRUSP2CYP2D6 | |
| SCHEMBL27371805 | 0.91 | CDC25A (0.66) | CDC25APOLA1VDRUSP2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11112654-B2 | Liquid crystal display device | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2021-09-07 | — | — | US | disclosed |
| US-11028323-B2 | Liquid crystal aligning agent containing crosslinking agent and polymer that has site having isocyanate group and/or blocked isocyanate group and site having photoreactivity, liquid crystal alignment film, and liquid crystal display element | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2021-06-08 | — | — | US | disclosed |
| US-10921650-B2 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2021-02-16 | — | — | US | disclosed |
| US-20200347226-A1 | RESIN COMPOSITION FOR INSULATING FILM | NISSAN CHEMICAL CORPORATION (JP) | 2020-11-05 | — | — | US | disclosed |
| US-10761375-B2 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2020-09-01 | — | — | US | disclosed |
| US-10545382-B2 | Liquid crystal display device and alignment film | SHARP KABUSHIKI KAISHA (JP) | 2020-01-28 | — | — | US | disclosed |
| WO-2019139028-A1 | RESIN COMPOSITION FOR INSULATING FILM | 日産化学株式会社 | 2019-07-18 | — | — | WO | disclosed |
| US-20190023987-A1 | LIQUID CRYSTAL ALIGNING AGENT CONTAINING CROSSLINKING AGENT AND POLYMER THAT HAS SITE HAVING ISOCYANATE GROUP AND/OR BLOCKED ISOCYANATE GROUP AND SITE HAVING PHOTOREACTIVITY, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-01-24 | — | — | US | disclosed |
| US-20190018289-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-01-17 | — | — | US | disclosed |
| US-10011772-B2 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-20160244673-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-08-25 | — | — | US | disclosed |
| US-20160244673-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-08-25 | — | — | US | disclosed |
| US-8901353-B2 | Polyimide precursor, polyimide, and liquid crystal aligning agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-8901353-B2 | Polyimide precursor, polyimide, and liquid crystal aligning agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-8829153-B2 | Polyimide precursor composition containing polyamic acid alkyl ester | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-09-09 | — | — | US | disclosed |
| US-8829153-B2 | Polyimide precursor composition containing polyamic acid alkyl ester | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-09-09 | — | — | US | disclosed |
| US-20120101236-A1 | POLYIMIDE PRECURSOR COMPOSITION CONTAINING POLYAMIC ACID ALKYL ESTER | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20120101236-A1 | POLYIMIDE PRECURSOR COMPOSITION CONTAINING POLYAMIC ACID ALKYL ESTER | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | PUF60, F13A1, F12 | CDC25A 674/4885POLA1 322/4885VDR 4603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.